Published in Antimicrob Resist Infect Control on February 14, 2012
Nosocomial infection and antibiotic use: a second national prevalence study in Germany. Dtsch Arztebl Int (2013) 1.98
Management options for reducing the release of antibiotics and antibiotic resistance genes to the environment. Environ Health Perspect (2013) 1.42
Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control (2012) 1.10
European Antibiotic Awareness Day 2012: TARGET antibiotics through guidance, education, and tools. Br J Gen Pract (2012) 1.09
Effectiveness of steam inhalation and nasal irrigation for chronic or recurrent sinus symptoms in primary care: a pragmatic randomized controlled trial. CMAJ (2016) 1.07
Mobile genetic elements of the human gastrointestinal tract: potential for spread of antibiotic resistance genes. Gut Microbes (2013) 1.02
Synergistic effect between colistin and bacteriocins in controlling Gram-negative pathogens and their potential to reduce antibiotic toxicity in mammalian epithelial cells. Antimicrob Agents Chemother (2013) 0.95
Antimicrobial resistance: a global multifaceted phenomenon. Pathog Glob Health (2015) 0.87
Identification of anziaic acid, a lichen depside from Hypotrachyna sp., as a new topoisomerase poison inhibitor. PLoS One (2013) 0.86
Prospects for circumventing aminoglycoside kinase mediated antibiotic resistance. Front Cell Infect Microbiol (2013) 0.85
Antimicrobial agent exposure and the emergence and spread of resistant microorganisms: issues associated with study design. Eur J Clin Microbiol Infect Dis (2012) 0.85
Insects represent a link between food animal farms and the urban environment for antibiotic resistance traits. Appl Environ Microbiol (2014) 0.84
Antibiotic resistance is widespread in urban aquatic environments of Rio de Janeiro, Brazil. Microb Ecol (2014) 0.83
Can we prevent antimicrobial resistance by using antimicrobials better? Pathogens (2013) 0.82
Interaction of graphene family materials with Listeria monocytogenes and Salmonella enterica. Nanoscale Res Lett (2015) 0.82
Prevalence of 16S rRNA methylase genes among β-lactamase-producing Enterobacteriaceae clinical isolates in Saudi Arabia. Libyan J Med (2014) 0.82
Reclaimed water as a reservoir of antibiotic resistance genes: distribution system and irrigation implications. Front Microbiol (2013) 0.81
Antimicrobial susceptibility trends among gram-positive and -negative clinical isolates collected between 2005 and 2012 in Mexico: results from the Tigecycline Evaluation and Surveillance Trial. Ann Clin Microbiol Antimicrob (2015) 0.81
Appearance of β-lactam Resistance Genes in Agricultural Soils and Clinical Isolates over the 20(th) Century. Sci Rep (2016) 0.80
Delta Procalcitonin Is a Better Indicator of Infection Than Absolute Procalcitonin Values in Critically Ill Patients: A Prospective Observational Study. J Immunol Res (2016) 0.80
Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems. Arch Med Sci (2015) 0.79
A pivot mutation impedes reverse evolution across an adaptive landscape for drug resistance in Plasmodium vivax. Malar J (2016) 0.79
Conservative fluid therapy in septic shock: an example of targeted therapeutic minimization. Crit Care (2014) 0.79
Streptomycin Induced Stress Response in Salmonella enterica Serovar Typhimurium Shows Distinct Colony Scatter Signature. PLoS One (2015) 0.78
A prediction tool for nosocomial multi-drug Resistant Gram-Negative Bacilli infections in critically ill patients - prospective observational study. BMC Infect Dis (2014) 0.78
Development of Cefotaxime Impregnated Chitosan as Nano-antibiotics: De Novo Strategy to Combat Biofilm Forming Multi-drug Resistant Pathogens. Front Microbiol (2016) 0.78
Antimicrobial Susceptibility of Klebsiella pneumoniae and Escherichia coli with Extended-Spectrum β-lactamase associated Genes in Hospital Tengku Ampuan Afzan, Kuantan, Pahang. Malays J Med Sci (2016) 0.77
Antibiotic management teams in Belgian hospitals: continued improvement in the period from 2007 to 2011. Eur J Clin Microbiol Infect Dis (2014) 0.77
The multidrug resistance IncA/C transferable plasmid encodes a novel domain-swapped dimeric protein-disulfide isomerase. J Biol Chem (2013) 0.77
Of creatures great and small: the advantages of farm animal models in immunology research. Front Immunol (2013) 0.77
Changes in the prevalence and biofilm formation of Haemophilus influenzae and Haemophilus parainfluenzae from the respiratory microbiota of patients with sarcoidosis. BMC Infect Dis (2016) 0.77
Antibiotic prescribing and resistance: knowledge level of medical students of clinical years of University Sultan Zainal Abidin, Malaysia. Ther Clin Risk Manag (2016) 0.77
Six years of a national antimicrobial stewardship programme in Scotland: where are we now? Antimicrob Resist Infect Control (2015) 0.77
Phase I Study Assessing the Pharmacokinetic Profile, Safety, and Tolerability of a Single Dose of Ceftazidime-Avibactam in Hospitalized Pediatric Patients. Antimicrob Agents Chemother (2016) 0.77
Evaluating the toxic effect of an antimicrobial agent on single bacterial cells with optical tweezers. Biomed Opt Express (2014) 0.76
Carbapenem MICs in Escherichia coli and Klebsiella Species Producing Extended-Spectrum β-Lactamases in Critical Care Patients from 2001 to 2009. Antimicrob Agents Chemother (2017) 0.75
Human Cystic Fibrosis Macrophages Have Defective Calcium-Dependent Protein Kinase C Activation of the NADPH Oxidase, an Effect Augmented by Burkholderia cenocepacia. J Immunol (2017) 0.75
"The Chennai declaration" - Indian doctors' fight against antimicrobial resistance. Antimicrob Resist Infect Control (2013) 0.75
What are the threats from antimicrobial resistance for maternity units in low- and middle- income countries? Glob Health Action (2016) 0.75
Save Antibiotics: a call for action of the World Alliance Against Antibiotic Resistance (WAAAR). BMC Infect Dis (2014) 0.75
Diagnostic methods for mastitis in cows are not appropriate for use in humans: commentary. Int Breastfeed J (2016) 0.75
Synergistic Nisin-Polymyxin Combinations for the Control of Pseudomonas Biofilm Formation. Front Microbiol (2016) 0.75
Antimicrobial Use and Veterinary Care among Agro-Pastoralists in Northern Tanzania. PLoS One (2017) 0.75
Carbapenem-Resistant Klebsiella pneumoniae Infection in Three New York City Hospitals Trended Downwards From 2006 to 2014. Open Forum Infect Dis (2016) 0.75
Detection of Salmonella spp. with the BACTEC 9240 Automated Blood Culture System in 2008 - 2014 in Southern Iran (Shiraz): Biogrouping, MIC, and Antimicrobial Susceptibility Profiles of Isolates. Jundishapur J Microbiol (2016) 0.75
Bacteriocins synthesized by Bacillus thuringiensis: generalities and potential applications. Rev Med Microbiol (2016) 0.75
The use of minimum selectable concentrations (MSCs) for determining the selection of antimicrobial resistant bacteria. Ecotoxicology (2017) 0.75
A membrane computing simulator of trans-hierarchical antibiotic resistance evolution dynamics in nested ecological compartments (ARES). Biol Direct (2015) 0.75
Temporal trends of healthcare associated infections and antimicrobial use in 2011-2013, observed with annual point prevalence surveys in Ferrara University Hospital, Italy. J Prev Med Hyg (2016) 0.75
Relative efficacy of organic acids and antibiotics as growth promoters in broiler chicken. Vet World (2016) 0.75
Prevalence and antibiotic resistance of coagulase-negative Staphylococci isolated from poultry farms in three regions of Ghana. Infect Drug Resist (2017) 0.75
New Insights about Antibiotic Production by Pseudomonas aeruginosa: A Gene Expression Analysis. Front Chem (2017) 0.75
A retrospective study of antibiotic de-escalation in patients with ventilator-associated pneumonia in Malaysia. Int J Clin Pharm (2017) 0.75
Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis (2010) 35.92
Bad bugs, no drugs: no ESKAPE! An update from the Infectious Diseases Society of America. Clin Infect Dis (2009) 22.98
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship. Clin Infect Dis (2006) 14.63
Essential oils: their antibacterial properties and potential applications in foods--a review. Int J Food Microbiol (2004) 13.51
Use of procalcitonin to reduce patients' exposure to antibiotics in intensive care units (PRORATA trial): a multicentre randomised controlled trial. Lancet (2010) 7.61
Intervention to reduce transmission of resistant bacteria in intensive care. N Engl J Med (2011) 7.07
Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis (2011) 6.57
The 10 x '20 Initiative: pursuing a global commitment to develop 10 new antibacterial drugs by 2020. Clin Infect Dis (2010) 5.58
Hospital and societal costs of antimicrobial-resistant infections in a Chicago teaching hospital: implications for antibiotic stewardship. Clin Infect Dis (2009) 4.87
Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis (2007) 4.69
Methicillin-resistant Staphylococcus aureus (MRSA) strain ST398 is present in midwestern U.S. swine and swine workers. PLoS One (2008) 4.60
Tackling antibiotic resistance. Nat Rev Microbiol (2011) 3.95
German outbreak of Escherichia coli O104:H4 associated with sprouts. N Engl J Med (2011) 3.69
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Immunotherapy for sepsis--a new approach against an ancient foe. N Engl J Med (2010) 3.62
Extended-spectrum β-lactamase genes of Escherichia coli in chicken meat and humans, The Netherlands. Emerg Infect Dis (2011) 3.37
Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. Clin Infect Dis (2011) 2.89
Mortality and hospital stay associated with resistant Staphylococcus aureus and Escherichia coli bacteremia: estimating the burden of antibiotic resistance in Europe. PLoS Med (2011) 2.72
Significant reduction of antibiotic use in the community after a nationwide campaign in France, 2002-2007. PLoS Med (2009) 2.70
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
Preserving the lifesaving power of antimicrobial agents. JAMA (2011) 2.31
Evidence of increasing antibiotic resistance gene abundances in archived soils since 1940. Environ Sci Technol (2010) 2.23
Consumer attitudes and use of antibiotics. Emerg Infect Dis (2003) 2.20
Antibiotic prescribing in hospitals: a social and behavioural scientific approach. Lancet Infect Dis (2010) 2.12
Determinants of self-medication with antibiotics in Europe: the impact of beliefs, country wealth and the healthcare system. J Antimicrob Chemother (2008) 2.11
Antimicrobial resistance among Campylobacter strains, United States, 1997-2001. Emerg Infect Dis (2004) 2.07
Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection (2011) 2.00
Methicillin resistant Staphylococcus aureus ST398 in veal calf farming: human MRSA carriage related with animal antimicrobial usage and farm hygiene. PLoS One (2010) 1.98
To use or not to use? Polyclonal intravenous immunoglobulins for the treatment of sepsis and septic shock. Crit Care Med (2007) 1.92
Curbing methicillin-resistant Staphylococcus aureus in 38 French hospitals through a 15-year institutional control program. Arch Intern Med (2010) 1.91
Bacteriophages: an appraisal of their role in the treatment of bacterial infections. Int J Antimicrob Agents (2007) 1.70
Self-medication with antibiotics--does it really happen in Europe? Health Policy (2005) 1.67
The crisis of no new antibiotics--what is the way forward? Lancet Infect Dis (2011) 1.65
Outpatient antibiotic use and prevalence of antibiotic-resistant pneumococci in France and Germany: a sociocultural perspective. Emerg Infect Dis (2002) 1.57
Impact of a 16-community trial to promote judicious antibiotic use in Massachusetts. Pediatrics (2008) 1.55
[Impact of regulatory measures in the trends of community consumption of antibiotics in Chile]. Rev Med Chil (2002) 1.53
Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother (2007) 1.53
Will longer antimicrobial patents improve global public health? Lancet Infect Dis (2007) 1.53
Antibacterial agents: back to the future? Can we live with only colistin, co-trimoxazole and fosfomycin? Clin Microbiol Infect (2012) 1.45
Trends among pathogens reported as causing bacteraemia in England, 2004-2008. Clin Microbiol Infect (2011) 1.44
Comparison of the sales of veterinary antibacterial agents between 10 European countries. J Antimicrob Chemother (2010) 1.44
Critical shortage of new antibiotics in development against multidrug-resistant bacteria-Time to react is now. Drug Resist Updat (2011) 1.40
Procalcitonin for guidance of antibiotic therapy. Expert Rev Anti Infect Ther (2010) 1.39
Oral antibiotic use without consulting a physician: a survey of ED patients. Am J Emerg Med (2001) 1.38
Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection. Eur Respir J (2010) 1.38
Videos in clinical medicine. Hand hygiene. N Engl J Med (2011) 1.38
Escherichia coli and Staphylococcus aureus: bad news and good news from the European Antimicrobial Resistance Surveillance Network (EARS-Net, formerly EARSS), 2002 to 2009. Euro Surveill (2011) 1.34
International spread of multidrug-resistant Salmonella Schwarzengrund in food products. Emerg Infect Dis (2007) 1.34
Development of a vaccine against Staphylococcus aureus. Semin Immunopathol (2011) 1.32
Colistin pharmacokinetics: the fog is lifting. Clin Microbiol Infect (2011) 1.30
When carbapenem-hydrolyzing beta-lactamase Kpc meets Escherichia coli ST131 in France. Antimicrob Agents Chemother (2011) 1.30
Increasing the efficiency of clinical trials of antimicrobials: the scientific basis of substantial evidence of effectiveness of drugs. Clin Infect Dis (2007) 1.26
Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC Point Prevalence Survey 2009. J Antimicrob Chemother (2010) 1.23
Antimicrobial drug development--the past, the present, and the future. Clin Microbiol Infect (2004) 1.21
French national program for prevention of healthcare-associated infections and antimicrobial resistance, 1992-2008: positive trends, but perseverance needed. Infect Control Hosp Epidemiol (2009) 1.17
Road to clinical efficacy: challenges and novel strategies for antimicrobial peptide development. Future Microbiol (2011) 1.16
The First Global Patient Safety Challenge "Clean Care is Safer Care": from launch to current progress and achievements. J Hosp Infect (2007) 1.14
Diagnostics as essential tools for containing antibacterial resistance. Drug Resist Updat (2011) 1.12
Priority actions to fight antibiotic resistance: results of an international meeting. Antimicrob Resist Infect Control (2012) 1.10
Nationwide implementation of antibiotic management teams in Belgian hospitals: a self-reporting survey. J Antimicrob Chemother (2010) 1.07
Antibiotic overuse: the influence of social norms. J Am Coll Surg (2008) 1.07
Methicillin-resistant Staphylococcus aureus ST398, Italy. Emerg Infect Dis (2010) 1.04
Impact of antibiotic restrictions: the pharmaceutical perspective. Clin Microbiol Infect (2006) 1.01
Availability of antibiotics for purchase without a prescription on the internet. Ann Fam Med (2009) 0.97
What are school children in Europe being taught about hygiene and antibiotic use? J Antimicrob Chemother (2011) 0.95
Abolishing user fees in Africa. PLoS Med (2009) 0.93
Evaluating the online activity of users of the e-Bug web site. J Antimicrob Chemother (2011) 0.88
Reduction in antibiotic use following a cluster randomized controlled multifaceted intervention: the Israeli judicious antibiotic prescription study. Clin Infect Dis (2011) 0.87
"Antibiotics are not automatic anymore"--the French national campaign to cut antibiotic overuse. PLoS Med (2009) 0.87
Impact of rapid antigen detection testing on antibiotic prescription in acute pharyngitis in adults. FARINGOCAT STUDY: a multicentric randomized controlled trial. BMC Fam Pract (2010) 0.87
Susceptibility of European Escherichia coli clinical isolates from intra-abdominal infections, extended-spectrum β-lactamase occurrence, resistance distribution, and molecular characterization of ertapenem-resistant isolates (SMART 2008-2009). Clin Microbiol Infect (2011) 0.85
Resistance genes traveling the microbial internet: down the drain, up the food chain? Expert Rev Anti Infect Ther (2009) 0.84
Recommendations for improving the design, conduct, and analysis of clinical trials in hospital-acquired pneumonia and ventilator-associated pneumonia. Clin Infect Dis (2010) 0.83
Professional challenges and opportunities in clinical microbiology and infectious diseases in Europe. Lancet Infect Dis (2011) 0.81
[Stop bacterial resistance: save antibiotics]. Med Mal Infect (2011) 0.78
Antibiotic resistance-the need for global solutions. Lancet Infect Dis (2013) 15.01
A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis. Science (2004) 13.04
Preventing surgical-site infections in nasal carriers of Staphylococcus aureus. N Engl J Med (2010) 8.50
Universal screening for methicillin-resistant Staphylococcus aureus at hospital admission and nosocomial infection in surgical patients. JAMA (2008) 7.60
Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet (2010) 6.16
The impact of methicillin resistance in Staphylococcus aureus bacteremia on patient outcomes: mortality, length of stay, and hospital charges. Infect Control Hosp Epidemiol (2005) 5.86
Risk and outcome of nosocomial Staphylococcus aureus bacteraemia in nasal carriers versus non-carriers. Lancet (2004) 5.27
EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists. Rhinology (2012) 4.83
International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum beta-lactamase production in nosocomial Infections. Ann Intern Med (2004) 4.75
Emergence of methicillin-resistant Staphylococcus aureus of animal origin in humans. Emerg Infect Dis (2007) 4.69
Limited efficacy of alcohol-based hand gels. Lancet (2002) 4.65
Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis (2012) 4.62
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis. Am J Med (2003) 4.56
Guideline for Hand Hygiene in Health-Care Settings: recommendations of the Healthcare Infection Control Practices Advisory Committee and the HICPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Infect Control Hosp Epidemiol (2002) 4.26
Procalcitonin guidance of antibiotic therapy in community-acquired pneumonia: a randomized trial. Am J Respir Crit Care Med (2006) 4.15
Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns. Emerg Infect Dis (2002) 4.08
European Position Paper on Rhinosinusitis and Nasal Polyps 2012. Rhinol Suppl (2012) 3.98
Community-acquired MRSA and pig-farming. Ann Clin Microbiol Antimicrob (2006) 3.80
Antibiotic therapy for Klebsiella pneumoniae bacteremia: implications of production of extended-spectrum beta-lactamases. Clin Infect Dis (2004) 3.75
Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis (2010) 3.65
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. Lancet Infect Dis (2003) 3.33
Prevention of severe Candida infections in nonneutropenic, high-risk, critically ill patients: a randomized, double-blind, placebo-controlled trial in patients treated by selective digestive decontamination. Intensive Care Med (2002) 3.33
Rapid detection of methicillin-resistant Staphylococcus aureus directly from sterile or nonsterile clinical samples by a new molecular assay. J Clin Microbiol (2003) 3.27
Epidemiology of candidemia in Swiss tertiary care hospitals: secular trends, 1991-2000. Clin Infect Dis (2004) 3.25
Meticillin-resistant Staphylococcus aureus. Lancet Infect Dis (2005) 3.18
Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomised double-blind trial. Lancet (2007) 3.11
Preventing the spread of MRSA. BMJ (2004) 2.91
Use of procalcitonin to shorten antibiotic treatment duration in septic patients: a randomized trial. Am J Respir Crit Care Med (2007) 2.88
Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med (2004) 2.84
Developed-developing country partnerships: benefits to developed countries? Global Health (2012) 2.80
Health-care workers: source, vector, or victim of MRSA? Lancet Infect Dis (2008) 2.79
Guideline for Hand Hygiene in Health-Care Settings. Recommendations of the Healthcare Infection Control Practices Advisory Committee and the HIPAC/SHEA/APIC/IDSA Hand Hygiene Task Force. Am J Infect Control (2002) 2.68
Antimicrobial drug use and resistance in Europe. Emerg Infect Dis (2008) 2.68
Patient participation: current knowledge and applicability to patient safety. Mayo Clin Proc (2010) 2.66
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother (2011) 2.58
Society's failure to protect a precious resource: antibiotics. Lancet (2011) 2.51
Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections. Emerg Infect Dis (2007) 2.49
Helicobacter pylori resistance to antibiotics in Europe and its relationship to antibiotic consumption. Gut (2012) 2.49
Presence of a novel DNA methylation enzyme in methicillin-resistant Staphylococcus aureus isolates associated with pig farming leads to uninterpretable results in standard pulsed-field gel electrophoresis analysis. J Clin Microbiol (2006) 2.43
The effect of workload on infection risk in critically ill patients. Crit Care Med (2007) 2.42
Adequacy of antimicrobial treatment and outcome of Staphylococcus aureus bacteremia in 9 Western European countries. Clin Infect Dis (2009) 2.39
Antibiotic selection pressure and resistance in Streptococcus pneumoniae and Streptococcus pyogenes. Emerg Infect Dis (2004) 2.35
Successful implementation of the World Health Organization hand hygiene improvement strategy in a referral hospital in Mali, Africa. Infect Control Hosp Epidemiol (2010) 2.35
Livestock-associated methicillin-resistant Staphylococcus aureus in humans, Europe. Emerg Infect Dis (2011) 2.35
Assessment of clarithromycin susceptibility in strains belonging to the Mycobacterium abscessus group by erm(41) and rrl sequencing. Antimicrob Agents Chemother (2010) 2.34
Low apolipoprotein A-I level at intensive care unit admission and systemic inflammatory response syndrome exacerbation. Crit Care Med (2004) 2.33
Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes. Antimicrob Agents Chemother (2006) 2.32
European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe. J Antimicrob Chemother (2006) 2.32
A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis (2003) 2.29
Detection by GenoType MTBDRsl test of complex mechanisms of resistance to second-line drugs and ethambutol in multidrug-resistant Mycobacterium tuberculosis complex isolates. J Clin Microbiol (2010) 2.26
A randomized clinical trial to compare fleroxacin-rifampicin with flucloxacillin or vancomycin for the treatment of staphylococcal infection. Clin Infect Dis (2004) 2.22
Health-care-associated infection in Africa: a systematic review. Bull World Health Organ (2011) 2.18
In vitro and in vivo activities of rifampin, streptomycin, amikacin, moxifloxacin, R207910, linezolid, and PA-824 against Mycobacterium ulcerans. Antimicrob Agents Chemother (2006) 2.16
Global implementation of WHO's multimodal strategy for improvement of hand hygiene: a quasi-experimental study. Lancet Infect Dis (2013) 2.15
Prevalence of livestock-associated MRSA in communities with high pig-densities in The Netherlands. PLoS One (2010) 2.11
Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia. BMC Infect Dis (2007) 2.11
Development of a multiplex PCR for the detection of asa1, gelE, cylA, esp, and hyl genes in enterococci and survey for virulence determinants among European hospital isolates of Enterococcus faecium. J Clin Microbiol (2004) 2.10
Carriage of methicillin-resistant Staphylococcus aureus in home care settings: prevalence, duration, and transmission to household members. Arch Intern Med (2009) 2.07
Infection in breast implants. Lancet Infect Dis (2005) 2.06
Bactericidal activity of rifampin-amikacin against Mycobacterium ulcerans in mice. Antimicrob Agents Chemother (2002) 2.05
Prevalence and resistance of commensal Staphylococcus aureus, including meticillin-resistant S aureus, in nine European countries: a cross-sectional study. Lancet Infect Dis (2013) 2.04
Appropriate international measures for outpatient antibiotic prescribing and consumption: recommendations from a national data comparison of different measures. J Antimicrob Chemother (2013) 2.04
The World Health Organization hand hygiene observation method. Am J Infect Control (2009) 2.01
Evaluation of three molecular assays for rapid identification of methicillin-resistant Staphylococcus aureus. J Clin Microbiol (2007) 1.97
Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity. Antimicrob Agents Chemother (2004) 1.96
Interventional study to evaluate the impact of an alcohol-based hand gel in improving hand hygiene compliance. Pediatr Infect Dis J (2002) 1.92
Evaluating the probability of previously unknown carriage of MRSA at hospital admission. Am J Med (2006) 1.90
Does antibiotic selection impact patient outcome? Clin Infect Dis (2006) 1.88
A call for action: the application of The International Health Regulations to the global threat of antimicrobial resistance. PLoS Med (2011) 1.88
Use of an automated multiple-locus, variable-number tandem repeat-based method for rapid and high-throughput genotyping of Staphylococcus aureus isolates. J Clin Microbiol (2005) 1.88
Comparison and evaluation of real-time PCR, real-time nucleic acid sequence-based amplification, conventional PCR, and serology for diagnosis of Mycoplasma pneumoniae. J Clin Microbiol (2003) 1.87
Evaluation of rapid screening and pre-emptive contact isolation for detecting and controlling methicillin-resistant Staphylococcus aureus in critical care: an interventional cohort study. Crit Care (2006) 1.86
Evaluation of real-time PCR for detection of and discrimination between Bordetella pertussis, Bordetella parapertussis, and Bordetella holmesii for clinical diagnosis. J Clin Microbiol (2003) 1.85
Induction of complete and molecular remissions in acute myeloid leukemia by Wilms' tumor 1 antigen-targeted dendritic cell vaccination. Proc Natl Acad Sci U S A (2010) 1.84
Longitudinal left ventricular function for prediction of survival in systemic light-chain amyloidosis: incremental value compared with clinical and biochemical markers. J Am Coll Cardiol (2012) 1.84
Identification of a novel plasmid-mediated colistin-resistance gene, mcr-2, in Escherichia coli, Belgium, June 2016. Euro Surveill (2016) 1.84
Current trends in rapid diagnostics for methicillin-resistant Staphylococcus aureus and glycopeptide-resistant enterococcus species. J Clin Microbiol (2008) 1.81
Combinations of R207910 with drugs used to treat multidrug-resistant tuberculosis have the potential to shorten treatment duration. Antimicrob Agents Chemother (2006) 1.81
Methicillin-resistant Staphylococcus aureus in veterinary doctors and students, the Netherlands. Emerg Infect Dis (2006) 1.80
Novel types of staphylococcal cassette chromosome mec elements identified in clonal complex 398 methicillin-resistant Staphylococcus aureus strains. Antimicrob Agents Chemother (2011) 1.75
Performance of the genotype MTBDR line probe assay for detection of resistance to rifampin and isoniazid in strains of Mycobacterium tuberculosis with low- and high-level resistance. J Clin Microbiol (2006) 1.71
Fluoroquinolone-containing third-line regimen against Mycobacterium tuberculosis in vivo. Antimicrob Agents Chemother (2003) 1.71
Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Crit Care (2006) 1.70
Noma: an "infectious" disease of unknown aetiology. Lancet Infect Dis (2003) 1.70
Foreign body infections due to Staphylococcus epidermidis. Ann Med (2009) 1.66
A novel multiplex real-time PCR assay for rapid typing of major staphylococcal cassette chromosome mec elements. J Clin Microbiol (2004) 1.63